Kevin Kabler, Ph.D.

USPTO And EPO Examiners Discuss Key Considerations For Filing Effective Precision Medicine And Bioinformatics Applications In The US And Europe

A More Consistent USPTO Approach To Patent Eligibility

Divided Infringement Challenges For Personalized Medicine

Burden Of Section 101 Following Myriad

Containing Myriad